As you know, it's not the first time we talk about the Youtube channel Bloomberg Television on Croblanc, and each time it always captivates you so much! At the same time, we understand you, the contents that we find there are simply unique. And so we decided to share with you today this latest content that might spark your interest.
As usual when the Youtube channel Bloomberg Television posts new content on the internet, you can find it on our site. To watch the latest video called "Novo Nordisk Sees Strong Demand for Obesity Drug", it's just above!
Very good feedback for the moment for the latest video of the Youtube channel Bloomberg Television, even if it is often the case on the comments found on this channel that users love for a long time now. If the feedback continues to be so positive, Google's algorithm could decide to propose it to many users.
Internet users can sometimes encounter problems with a video, or simply want to transmit information following an error in the editing for example. If you want to give feedback to the creator of the video, feel free to contact the author by going to the "About" section of his youtube channel. Or simply try to reach him on his social networks, it's quite convenient sometimes to tweet!
We are almost at the end of the news about the video Novo Nordisk Sees Strong Demand for Obesity Drug, all the team Croblanc hopes that you found it interesting to read. When we write an article and we see that it gets views because our community likes it, we can't wait to convince you to come back and read us more often! So do us a favor and come back regularly on Croblanc to follow other videos of Bloomberg Television.
And here it is already finished, we will see you very soon on Croblanc for a new article. Kisses, kisses, kisses!
For your information, you can find below the description of the video Novo Nordisk Sees Strong Demand for Obesity Drug published by the Youtube channel Bloomberg Television:
Novo Nordisk A/S will sell its Wegovy obesity drug in larger European markets in 2023 after resolving production problems that has held back sales of the weekly injection in the US. Chief Executive Officer Lars Fruergaard Jorgensen speaks on "Bloomberg Markets."
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en